Lightcalls.com
 

Tom, a 56-year-old private contract...

Tom, a 56-year-old private contractor in East Quogue of the present day York, woke up one Tuesday morning feeling disclosed of sorts. He hadn't been feeling well for several days, if it be not that now he felt worse. in succession his way to work, Tom's chest pain began.

He'd been to the sudden [i]or[/i] unexpected occurrence room twice in the past week, moreover the doctor assured him that he just had stomach point to be solved [i]or[/i] settleds The antacids, however, weren't helping, and the chest pain was getting worse. Tom started to perceive lightheaded and weak. Something was highly wrong.

By the time he reached the do job-work site, he could barely talk. "Get me to a hospital," he said, "I'm having a heart attack." His friend Paul pass by a leaped into the truck as Tom mov from one side of to the other to the passenger side. The pain had become unbearable, and as they plucked up to the hospital, Tom started to squander consciousness.

Holding onto Paul onward his way to the exigency room entrance, Tom fell to the landed estate His heart stopped. Clinically, he was dead.



Fortunately, help was conclude at hand. The medical team got Tom's heart going again and enjoin him on life support. Tom learned later that he'd sustained a massive heart attack. "I flatlined, I actually died," he says. "A give suck to even asked me if I'd seen the white light. Well, I hadn't. I wasn't wearing my glasses."

To the great relief of his family, Tom survived--and in the way that had his sense of humor.

An angiogram showed that sum of two units of Tom's major arteries were almost entirely blockadeed with fatty deposits--a condition commonly known as atherosclerosis. Tom was able to avoid major surgery moreover he required two stents--small devices impose inside clogged arteries to restrain them open.

"With today's high-tech regularitys they didn't even have to unclose up my chest," he says. "The s were inserted through an artery in my leg"

regaining from a heart attack is slow-going. "I have to deal with the cheap energy, the fear that it could happen again and the adjustment of taking all these medications for the stop of my life," says Tom. "It's been really hard upon my family too. I hate to behold my 10-year-old daughter look in the same manner worried. My wife had a panic attack and had to walk to the emergency room herself. And, of course, my contracting business went upon the back burner, which, in the height of work season, is a big problem"

Tom has had to make about major lifestyle adjustments and to deal with the depression and anxiety that frequently occur after a heart attack. He occasionally still has chest pains, and he's had to walk back to the emergency extent twice when it seemed his heartbeat wouldn't establish down.

Despite the emotional upheaval, Tom's recruiting is progressing well. His heart indicates all the important signs of healing, and the medications are working.

if it be not that the experience has left Tom with any very good questions--questions that everyone privations to know the answers to. "Weren't there any criterions that could have shown earlier upon that I was developing atherosclerosis?" he says. "Test that could count me why, after bringing my cholesterol down, I still got atherosclerosis? And what about those risk factors they talk about? I didn't have any of those."

standard cholesterol tests

Heart disease bring outs when there are too many fats or lipids in the children and doctors check for this according to testing total cholesterol level. Tom's doctors gave him a standard cholesterol example which reports the levels of total cholesterol (TC) high-density lipoproteins (HDLs) low-density lipoproteins (LDLs) and triglycerides (TG) at hand in the body (see "HDL and LDL explained", p 44)

The National Cholesterol Education Program (NCEP) places the desirable TC flat at 200 or below. TC on a levels between 200 and 240 are considered borderline high, and anything at or above 240 is considered a high risk for heart disease. According to NCEP guidelines, cholesterol-reducing put drugs intos are recommended for borderline flats only if the patient has brace or more additional major risk factors like as smoking or high vital current pressure.

According to his doctor, Tom didn't fall into the high-risk category for a heart attack. He didn't have any major risk factors other than borderline high cholesterol

nevertheless while Tom's cholesterol had been 270 at single point, he'd been able to bring it down to 220 with a regimen of diet, exercise and supplements

"My doctor wasn't worried, and neither was I," says Tom. "I started exercising regularly and was careful about my diet. I took complements and herbs, and my cholesterol came down. I had my family comely late in life, and I want to be around for awhile, likewise I'm really good about going for check-ups. I had a stres proof done three or four years ago, and the doctor said my heart would last until I was 95 They checked my carotid arteries with ultrasound. Everything read normal. No individual ever told me I was in a high-risk category."

early warning

Tom's case isn't unique. According to John forty rods ND, of Great Smokies Diagnostic Laboratory in Asheville, NC nearly half of all heart attacks strike family who don't know they're at risk--people without the typical risk factors of that kind as high cholesterol, hypertension, diabetes or smoking.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.